Patents/Assignees

G1 Therapeutics, Inc.

7 patents in portfolio

US12168666utility2024
Morphic Forms of Trilaciclib and Methods of Manufacture Thereof
0 cites
US12139494utility2024
Morphic Forms of G1T38 and Methods of Manufacture Thereof
0 cites
US11717523utility2023
Transient Protection of Normal Cells During Chemotherapy
0 cites
US11708337utility2023
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
0 cites
US11654148utility2023
Hspc-sparing Treatments for Rb-positive Abnormal Cellular Proliferation
0 cites
US11643416utility2023
Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c][1,2,4]triazin]-3′-ones as Cyclin-dependent Kinase Inhibitors
0 cites
US11629150utility2023
Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
0 cites